secwatch / observer
8-K filed June 4, 2026, 4:48 PM ET ticker SONM CIK 0001178697
other material confidence high sentiment negative materiality 0.75

DNA X terminates $500M equity line with Chardan Capital Markets

DNA X, Inc.

item 1.02item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DNA X, Inc. terminated Registration Rights Agreement with Chardan Capital Markets LLC (effective 2026-05-28).

Action
termination
Counterparty
Chardan Capital Markets LLC
Effective
2026-05-28
Exact text from the filing
On May 29, 2026, the Company and Chardan entered into a letter agreement pursuant to which they agreed, among other things, to terminate, effective as of 5:00 p.m., New York City time, on May 28, 2026, the ChEF Agreement and Registration Rights Agreement.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

DNA X, Inc. terminated ChEF Purchase Agreement with Chardan Capital Markets LLC valued at up to $500 million (effective 2026-05-28).

Action
termination
Agreement
equity purchase
Counterparty
Chardan Capital Markets LLC
Value
up to $500 million
Effective
2026-05-28
Exact text from the filing
On May 29, 2026, the Company and Chardan entered into a letter agreement pursuant to which they agreed, among other things, to terminate, effective as of 5:00 p.m., New York City time, on May 28, 2026, the ChEF Agreement and Registration Rights Agreement.
View on SEC.gov

Browse all material agreements →

DNA X, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-26-027295
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.